First Tracks Biotherapeutics, Inc. - 10-Q Filing
First Tracks Biotherapeutics reports Q3 2025 financial results and discloses subsequent private placement agreement in October 2026.
Tickers: $TRAX
Read the full article at SEC EDGAR
Part of the story FIRST UNITED CORP/MD/ - 10-Q Filing (3 articles)